FAKTOR ZERTIFIKAT LONG - ROCHE GS Share Price

Certificat

SROCL5

DE000SW8FYG0

Real-time Borsa Italiana 07:24:35 21/06/2024 pm IST
31.5 EUR +3.72% Intraday chart for FAKTOR ZERTIFIKAT LONG - ROCHE GS
Current month+52.69%
1 month+31.93%
Date Price Change
21/24/21 31.5 +3.72%
20/24/20 30.37 +1.20%
19/24/19 30.01 +4.17%
18/24/18 28.81 +3.97%
17/24/17 27.71 -1.81%

Real-time Borsa Italiana

Last update June 21, 2024 at 07:24 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
SROCL5
ISINDE000SW8FYG0
Date issued 08/04/2024
Maturity Unlimited
Parity 1 : 1
Emission price-
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 31.5
Lowest since issue 13.93
Spread 0.1
Spread %0.32%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
250 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.22%
Consensus
  1. Stock Market
  2. Certificates
  3. SROCL5 Certificat